Cellular senescence mediates the detrimental effect of prenatal dexamethasone exposure on postnatal long bone growth in mice offspring

Jianwen Su,Yu Chai,Zhiguo Ji,Yongheng Xie,Bin Yu,Xianrong Zhang
DOI: https://doi.org/10.21203/rs.3.rs-17277/v1
2020-03-15
Abstract:Abstract Background: Prenatal dexamethasone exposure (PDE) induces low birth weight and retardation of fetal bone development which are associated with lower peak bone mass in adult offspring. Here we evaluated whether and how PDE affects postnatal long bone growth in mice offspring.Methods: Pregnant mice were injected subcutaneously with dexamethasone (1.2 mg kg ̶ 1day ̶ 1) every morning from gestational day (GD) 12-14. Femurs and tibias of 2-, 4-, 6, 12-week-old female offspring were harvested for histological, immunofluoresence, flow cytometric analysis, or microcomputed tomography (μCT) measurement. Results: PDE results in impaired bone remodeling as well as decreased bone mass in the long bone of mice offspring. During postnatal bone growth, significant decrease of CD45-CD29+CD105+Sca-1+ bone marrow mesenchymal stem cells (BMSCs) and CD45-Nestin+ cells, loss of type H vessels as well as increment of cellular senescence were found in metaphysis of long bone in mice offspring after PDE. We further show that eliminating the excessive senescent cells with dasatinib (5 mg kg ̶ 1day ̶ 1) and quercetin (50 mg kg ̶ 1day ̶ 1) during GD 12-14 rescued the above toxic effect of PDE on the postnatal long bone growth in mice offspring.Conclusion: Cellular senescence mediates the toxic effect of PDE on postnatal long bone growth in mice offspring, and inhibition of cellular senescence may be proposed for treating retardation of bone growth caused by PDE.
What problem does this paper attempt to address?